Synergistic effects of elranatamab and Juzentaihoto, Japanese traditional herbal medicine, in triple-class-exposed relapsed/refractory multiple myeloma with extramedullary disease: a case report

Key Points

• Elranatamab and Juzentaihoto together improved outcomes in multiple myeloma with extramedullary disease.
• The patient experienced significant symptom relief after treatment, highlighting treatment efficacy.
• Case report featuring a triple-class-exposed relapsed/refractory multiple myeloma patient with extramedullary disease.
• Findings suggest potential for combining traditional herbal medicine with modern treatments.